The Expression of HMGA2 Varies Strongly among Colon Carcinomas
Anticancer Research, 05/21/2012
Helmke BM et al. – For high mobility group protein AT–hook2 (HMGA2)–based risk assessment, continuous rather than discontinuous models seem to be most appropriate. However, in daily practice, immunohistochemistry (IHC) seems to be a suitable method to stratify for high–risk patients.